aliskiren and Ovarian-Neoplasms

aliskiren has been researched along with Ovarian-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for aliskiren and Ovarian-Neoplasms

Article	Year
Should we use the angiotensin-converting enzyme inhibitors for the treatment of anti-VEGF-induced hypertension? Annals of oncology : official journal of the European Society for Medical Oncology, 2014, Volume: 25, Issue:8 Topics: Amides; Angiotensin-Converting Enzyme Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cohort Studies; Disease-Free Survival; Drug Substitution; Enalapril; Female; Fumarates; Humans; Hypertension; Ovarian Neoplasms; Perindopril; Protein Kinase Inhibitors; Recurrence; Vascular Endothelial Growth Factor A	2014

Article

Year

Should we use the angiotensin-converting enzyme inhibitors for the treatment of anti-VEGF-induced hypertension?

Annals of oncology : official journal of the European Society for Medical Oncology, 2014, Volume: 25, Issue:8

Topics: Amides; Angiotensin-Converting Enzyme Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cohort Studies; Disease-Free Survival; Drug Substitution; Enalapril; Female; Fumarates; Humans; Hypertension; Ovarian Neoplasms; Perindopril; Protein Kinase Inhibitors; Recurrence; Vascular Endothelial Growth Factor A

2014